PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25723A0023Oncotype DX prostate testing — Mdxhealth, Inc

Mdxhealth, Inc holds $2.1M across 37 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 2 related awards in the incumbent pipeline.

257-Network Contract Office 17 (36C257)
Awarding office
Mdxhealth, Inc
Recipient
—
Estimated value
Q301
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal
Contract number36C25723A0023
Also listed as36C257-23-A-0023
Agency257-Network Contract Office 17 (36C257)
Awarding office257-Network Contract Office 17 (36C257)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentMdxhealth, Inc
UEILQGYDJJ9K8Q6
PSCQ301
Related solicitation36C25723Q0646

ONCOTYPE DX PROSTATE TESTING is a federal award for 257-Network Contract Office 17 (36C257) held by Mdxhealth, Inc. Estimated value —. Related solicitation 36C25723Q0646.

Bonuses end Sept 30

Want the durability read on 36C25723A0023? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Mdxhealth, Inc — $2.1M obligated across 37 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)
Department of Veterans Affairs (VA)$2.1M · 100% of firm total
Open full company profile →

Related awards

Same incumbent
36C25926N0080
MDX HEALTH TESTING FOR VISN 19
$244K
Sep 30, 2026
36C25726N0262
ONCOTYPE DX PROSTATE TESTING
$319K
Apr 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C25723A0023?

36C25723A0023 (Oncotype DX prostate testing) is a 257-Network Contract Office 17 (36C257) award with an estimated value of —, currently held by Mdxhealth, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C257-23-A-0023?

36C257-23-A-0023 is the dashed form of PIID 36C25723A0023 (Oncotype DX prostate testing), held by Mdxhealth, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25723A0023?

257-Network Contract Office 17 (36C257) awarded 36C25723A0023 to Mdxhealth, Inc.

Who is the incumbent on 36C25723A0023?

Mdxhealth, Inc is the incumbent with $2.1M across 37 related awards in SCOUT’s public footprint.

When does Mdxhealth, Inc’s 36C25723A0023 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C25723A0023? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C25723A0023